Study on the application of propofol combined with different doses of alfentanil in hysteroscopic anesthesia

Study on the safety and effectiveness of propofol combined with different doses of alfentanil in hysteroscopic anesthesia

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100054520

Enrollment

Unknown

Registered

2021-12-19

Start date

2022-01-01

Completion date

Unknown

Last updated

2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial polyps

Interventions

Experimental group1:Fentanyl + Propofol

Experimental group2:Alfentanil 5ug/kg + Propofol

Experimental group3:Alfentanil 10ug/kg + Propofol

Eligibility

Sex/Gender

Female

Age

25 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing hysteroscopic surgery under elective general anesthesia, aged 25 to 55 years, ASA I-II grade; 2. The patient or family member is aware of this research plan and signs an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from high blood pressure, heart disease, severe liver and kidney disease, decompensated organ function, neuropsychiatric and other diseases; 2. Patients with upper respiratory tract obstructive diseases such as sleep apnea syndrome; 3. People who are allergic to drugs; 4. A recent history of upper respiratory tract infection.

Design outcomes

Primary

Measure	Time frame
Respiratory rate;	—

Countries

China

Contacts

Public ContactLiang Weidong

The First Affiliated Hospital of Gannan Medical University

lwd0929@gmu.edu.cn+86 15970122157

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026